The Pharmaceutical Market: Jordan

Summary

Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Jordan is a small but strategically located country in the Middle East, bordering Israel, Syria, Iraq and Saudi Arabia. Although it lacks the oil reserves of many of its neighbours and is relatively poor in comparison, it boasts good links with the West and is a key player on the local political scene.

Both the government and private sector are committed to upgrading and modernising Jordan's healthcare provision. The country has a reputation in the region for its high standards of services provided and both public and private hospitals have been expanding and upgrading in recent years.

Since its accession to the WTO, Jordan has demonstrated its commitment to WTO rules, in particular the TRIPS agreement, for example by recent improvements to, and enforcement of, IP protection. However, Jordan's regulatory environment is still being criticised, mainly by international manufacturers, who accuse Jordan of regulatory discrimination in favour of domestic producers.

Jordan has a relatively strong level of domestic production; however, the majority is exported, resulting in a market still dependent on imports. In 2005, Jordan imported pharmaceuticals valued at US$249.0 million, more than 80% of which was composed of retail medicaments. The EU and Switzerland were the leading suppliers in 2005, accounting for 75.4% of the market. Exports totalled US$286.8 million in 2005, primarily semi-finished and retail medicaments destined for other countries in the MENA region.

Content